Diabetes mellitus, type 2 Trials in Mangalore, India
Conditions / Diabetes mellitus, type 2 / Mangalore, India
Diabetes mellitus, type 2 is a medical condition with active clinical research programs worldwide.
14 total trials for this combination
Showing top 10 of 14 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02230618 | Post Marketing Surveillance (PMS) Study of Ryzodeg™ (Insulin Degludec/Insulin Aspart) in Patients With Diabetes Mellitus in Routine Clinical Practice in India | COMPLETED | — |
| NCT02065791 | Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy | COMPLETED | PHASE3 |
| NCT00968708 | Cardiovascular Outcomes Study of Alogliptin in Patients With Type 2 Diabetes and Acute Coronary Syndrome | COMPLETED | PHASE3 |
| NCT00295633 | A Study Assessing Saxagliptin Treatment in Type 2 Diabetic Subjects Who Are Not Controlled With TZD Therapy Alone | COMPLETED | PHASE3 |
| NCT01167881 | Efficacy and Safety of Empagliflozin (BI 10773) With Metformin in Patients With Type 2 Diabetes | COMPLETED | PHASE3 |
| NCT01032629 | CANVAS - CANagliflozin cardioVascular Assessment Study | COMPLETED | PHASE3 |
| NCT01045447 | Comparison of NN5401 With Insulin Glargine, Both in Combination With Oral Antidiabetic Drugs, in Subjects With Type 2 Diabetes | COMPLETED | PHASE3 |
| NCT01042769 | A Study With Aleglitazar in Patients With a Recent Acute Coronary Syndrome and Type 2 Diabetes Mellitus | COMPLETED | PHASE3 |
| NCT00736099 | Safety and Efficacy of Linagliptin (BI 1356) as Monotherapy or in Combination in Type 2 DM | COMPLETED | PHASE3 |
| NCT01164501 | Efficacy and Safety of Empagliflozin (BI 10773) in Patients With Type 2 Diabetes and Renal Impairment | COMPLETED | PHASE3 |